TISSUE CULTURE RESEARCH PAPER
==================================================

Title: Endocannabinoid‚Äêrelated compounds in gastrointestinal diseases

Authors: Unknown

Abstract:
Theendocannabinoidsystem(ECS)isanendogenoussignallingpathwayinvolvedinthecontrolofseveralgastrointestinal(GI)functionsat
bothperipheralandcentrallevels.Inrecentyears,ithasbecomeapparentthattheECSispivotalintheregulationofGImotility,secretionand
sensitivity,butendocannabinoids(ECs)arealsoinvolvedintheregulationofintestinalinflammationandmucosalbarrierpermeability,suggest-
ingtheirroleinthepathophysiologyofbothfunctionalandorganicGIdisorders.Geneticstudiesinpatientswithirritablebowelsyndrome(IBS)
orinflammatoryboweldiseasehaveindeedshownsignificantassociationswithpolymorphismsormutationingenesencodingforcannabinoid
receptororenzymeresponsiblefortheircatabolism,respectively.Furthermore,ongoingclinicaltrialsaretestingECagonists/antagonistsinthe
achievementofsymptomaticrelieffromanumberofGIsymptoms.Despitethisevidence,thereisalackofsupportiveRCTsandrelevantdata
inhumanbeings,andhence,thepossibletherapeuticapplicationofthesecompoundsisraisingethical,politicalandeconomicconcerns.More
recently,theidentificationofseveralEC-likecompoundsabletomodulateECSfunctionwithoutthetypicalcentralsideeffectsofcannabino-
mimeticshaspavedthewayforemergingperipherallyactingdrugs.ThisreviewsummarizesthepossiblemechanismslinkingtheECStoGI
disordersanddescribesthemostrecentadvancesinthemanipulationoftheECSinthetreatmentofGIdiseases.
Keywords:endocannabinoid system(cid:1)gastrointestinal pathophysiology(cid:1)functional gastrointestinal disorders(cid:1)non-alcoholic
steatohepatitis(cid:1)inflammatory bowel disease
